PLD Pharma Services operates an FDA-approved, pharmaceutical-grade facility in Copiague, New York dedicated to gummy manufacturing for nutritional, OTC, and Rx applications. Supported by a state-of-the-art R&D lab in Miami, PLD provides end-to-end formulation, scale-up, and commercial production — all under strict cGMP controls.
Science-Driven Formulation Expertise
PLD’s scientists draw on more than 30 years of experience developing dosage forms across tablets, capsules, softgels, and liquids, now applied to gummies with the same rigor and precision.
Key capabilities include:
- Starchless manufacturing for precise dosing, faster drying, and zero cross-contamination risk
- Dedicated suites and individual drying rooms to ensure product integrity
- Advanced flavor masking and active encapsulation to maintain taste, texture, and stability
- Comprehensive analytical and validation support to meet regulatory expectations
Precision, Purity, and Performance
PLD’s starchless process delivers uniform, stable gummies with pharmaceutical-level accuracy. Formulations are engineered to achieve optimal active-ingredient compatibility, pH balance, and mouthfeel, with typical dosage targets of 10–15% active weight to preserve quality and performance.
Scalable Capacity and Proven Leadership
With four production lines and an annual capacity exceeding 1.2 billion gummies, PLD is equipped to bring new products from bench to market efficiently.
Partner with PLD
PLD Pharma Services combines pharmaceutical science, regulatory expertise, and innovative formulation technology to deliver next-generation gummy dosage forms that meet the highest standards of accuracy, safety, and consumer appeal.